Form D · Other Health Care

Egaceutical Corp

La Jolla, CA · CIK 0001644330

Offering snapshot reported Jun 16, 2015 · SEC filing

Reported sold
Yet to sell
Offering amount: $25M
Investors reported
0
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 16, 2015InitialYet to sellNo comparison0SEC filing
Jun 16, 2015AmendmentYet to sellNo comparison0SEC filing
Jun 8, 2015Initial$9,000No comparison7SEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$2.5M (estimated)
Finders' fees
$0
Form D file number
021-241884
WestPark Capital, Inc., member FINRA, placement agent, is receiving 10% sales commission plus 3% non-accountable expense allowance, a $50,000 fee for general solicitation expense and 5 year warrants for 10% of stock issued in offering.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
WestPark Capital, Inc.39914

Source: Form D, filed Jun 16, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Beatrice Golomb Executive
Joel Huizenga Executive
David Huizenga Executive
Ved Pathak Executive
James Watson Executive
Gia Weisdorn Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
354 Gravilla Street
La Jolla, CA, 92037